| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Michael A Martino last filed a Form 4 in May 2023, as CEO at AMPE. Michael A Martino's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 76,890 shares of AMPE. Net of sales, the AMPE filings show accumulation of 76,890 shares.
Michael A Martino has 4 Form 4 filings on record from October 2021 to May 2023, all as CEO at Ampio Pharmaceuticals (AMPE), 2021–2023.
The 4 reported transactions were 3 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $22K and no sales.
The only open-market purchase was 76,890 shares of AMPE at an average $0.29 on May 24, 2023, about $22K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | AMPE Ampio Pharmaceuticals, Inc. | CEO | Buy | 76,890 | $0.29 | $22,121.25 | New |